Morgan Stanley Monte Rosa Therapeutics, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,255,353 shares of GLUE stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,255,353

Previous 125,332 1699.5%

Holding current value

$15 Million

Previous $664,000 2257.23%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.8 - $10.36 $10.2 Million - $22.1 Million	2,130,021 Added 1699.5%	2,255,353 $15.7 Million
Q3 2024 Nov 14, 2024	BUY	$3.59 - $6.97 $204,594 - $397,220	56,990 Added 83.39%	125,332 $664,000
Q2 2024 Oct 17, 2024	BUY	$3.38 - $7.86 $42,628 - $99,130	12,612 Added 22.63%	68,342 $255,000
Q2 2024 Aug 14, 2024	BUY	$3.38 - $7.86 $42,628 - $99,130	12,612 Added 22.63%	68,342 $255,000
Q1 2024 Oct 17, 2024	SELL	$4.26 - $8.46 $53,727 - $106,697	-12,612 Reduced 18.45%	55,730 $392,000
Q1 2024 Aug 16, 2024	SELL	$4.26 - $8.46 $109,677 - $217,811	-25,746 Reduced 31.6%	55,730 $392,000
Q1 2024 May 15, 2024	SELL	$4.26 - $8.46 $109,677 - $217,811	-25,746 Reduced 31.6%	55,730 $392,000
Q4 2023 Aug 16, 2024	BUY	$2.5 - $5.93 $32,835 - $77,884	13,134 Added 19.22%	81,476 $460,000
Q4 2023 Feb 13, 2024	BUY	$2.5 - $5.93 $113,525 - $269,281	45,410 Added 125.91%	81,476 $460,000
Q3 2023 Nov 15, 2023	SELL	$4.78 - $7.22 $71,766 - $108,401	-15,014 Reduced 29.39%	36,066 $172,000
Q2 2023 Aug 14, 2023	BUY	$4.53 - $8.4 $58,210 - $107,940	12,850 Added 33.61%	51,080 $349,000
Q1 2023 May 15, 2023	SELL	$5.95 - $8.21 $413,328 - $570,324	-69,467 Reduced 64.5%	38,230 $297,000
Q4 2022 Feb 14, 2023	SELL	$6.71 - $9.72 $96,798 - $140,220	-14,426 Reduced 11.81%	107,697 $819,000
Q3 2022 Nov 14, 2022	SELL	$7.17 - $12.16 $125,661 - $213,116	-17,526 Reduced 12.55%	122,123 $996,000
Q2 2022 Oct 27, 2022	BUY	$6.15 - $14.99 $30,565 - $74,500	4,970 Added 3.69%	139,649 $1.35 Million
Q2 2022 Aug 15, 2022	BUY	$6.15 - $14.99 $30,565 - $74,500	4,970 Added 3.69%	139,649 $1.35 Million
Q1 2022 Oct 27, 2022	SELL	$10.36 - $20.41 $51,489 - $101,437	-4,970 Reduced 3.56%	134,679 $1.89 Million
Q1 2022 May 13, 2022	SELL	$10.36 - $20.41 $13,053 - $25,716	-1,260 Reduced 0.93%	134,679 $1.89 Million
Q4 2021 Feb 14, 2022	BUY	$16.28 - $27.15 $684,378 - $1.14 Million	42,038 Added 44.77%	135,939 $2.78 Million
Q3 2021 Nov 15, 2021	BUY	$18.59 - $42.21 $1.75 Million - $3.96 Million	93,901 New	93,901 $2.09 Million

Others Institutions Holding GLUE

# of Institutions

107

Shares Held

53.8M

Call Options Held

276K

Put Options Held

15.9K

View Full List

About Monte Rosa Therapeutics, Inc.

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $310M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

More about GLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account